EN DE
Data-driven stock valuation

Procter & Gamble Company (PG) fair value: what the stock is really worth

We calculate from audited financials what Procter & Gamble Company is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily, free.

  1. Compare price with fair valuebelow fair value = cheap, above = expensive
  2. Check the quality50 and up solid, 75 and up strong
  3. Watch it or check another stockalert when fair value or trend changes

Consumer Defensive · US · Market cap $342B · ISIN US7427181091

At a glance

PG Procter & Gamble Company logo Procter & Gamble Company PG · US
Price$146.44
Fair Value$108.16
Upside−26.1%
Quality76/100

A strong business, but trading 35% above our fair value of $108.16.

As of Aug 30, 2026, the fair value of Procter & Gamble Company is $108.16 per share against a price of $146.44, so the fair value sits 26% below the price. A model estimate from reported figures, not an analyst target.

✓Healthy Growth (revenue 5y +3.5 %/yr)
✓Solidly profitable · 19.2% net margin
✓Low debt · generates free cash flow
·2.89% dividend yield
!Mixed vs. peers (7/15)
✓Wide moat 87/100
Evidence: High Range $70.77 to $151.46

Fair value as of: Aug 30, 2026

From 24 valuation models · updated 8 days ago

Share price −0.2% over the past month.

Watch Procter & Gamble Company for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

What matters now

  • A high-quality business (quality 76/100), yet the market already pays well above fair value. Quality at a full price, with little margin of safety.
  • A fairly wide model range ($70.77 to $151.46) leaves room in how you read the outcome.

Price vs Fair Value (5 years)

$172.51 $112.26 Fair Value $108.16 Jun 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 30, 2026.

How to read this chart

60‑month range $112.26 – $172.51 · fair‑value band $70.77 – $151.46 · the $146.44 price screens above the $108.16 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. Dashed = 300-day average. As of Aug 30, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Procter & Gamble Company (PG) currently trades at $146.44, while our model-based Fair Value estimate is $108.16, implying the stock looks roughly 35.4% overvalued today. The Quality Score stands at 76/100 (high quality), in the Consumer Defensive sector. Bull case: the Multiples group reads highest at a median of $116.62 per share, and 0 of the 24 models we run sit above the $146.44 price. Bear case: the Asset-Based group reads lowest at $14.97, and 24 of the 24 models stay below the price. Evidence for this calculation is high.

Over the trailing twelve months, Procter & Gamble Company generated revenue of $86.7B at a net margin of 19.2%. Revenue grew 7.4% year over year. It earns a return on equity of 31.1%. Net debt stands at $25.9B. Fundamentals as of Aug 30, 2026

Scenario range: $70.77 (bear) to $151.46 (bull), the price of $146.44 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target. The share trades about 12% below its 52-week high and 8% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at −34% fair-value upside, at −26%, PG screens cheaper than that median.

Fair Value models

Based on fiscal year 2025 figures (about 12 months old). Earnings retained since then ($2.61 per share) are deliberately not added.

Each model values the company its own way; the fair value above is the evidence-weighted blend. Evidence (0 to 100) shows how complete a model's inputs are. How we calculate →

Model Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
FCF DCF best evidence $59.29 $87.68 $131.41 80
Growth DCF $61.84 $89.08 $129.29 78
Owner Earnings $64.01 $94.42 $141.28 76
All 24 models by family
DCF Models
FCF DCF best evidence $59.29 $87.68 $131.41 80
Owner Earnings $64.01 $94.42 $141.28 76
5Y Revenue Exit $39.62 $58.26 $81.32 73
5Y EBITDA Exit $71.50 $113.77 $161.73 75
5Y P/E Exit $77.39 $124.02 $171.17 71
10Y Revenue Exit $45.12 $63.08 $83.95 67
10Y EBITDA Exit $66.45 $101.04 $142.17 68
10Y P/E Exit $70.18 $108.05 $149.00 64
Earnings-Based
Graham-Dodd $46.65 $94.44 $118.88 66
EPV $63.58 $75.97 $86.98 74
Dividend Discount
Gordon GGM $40.78 $60.44 $81.76 68
DDM Multi-Stage $40.78 $58.66 $80.22 67
Multiples
P/E Multiple $108.04 $144.06 $180.07 63
P/S Multiple $43.43 $57.91 $72.39 58
P/B Multiple $87.46 $116.62 $145.77 55
EV/EBIT $105.35 $142.67 $180.00 66
EV/EBITDA $90.92 $123.44 $155.95 67
EV/Revenue $31.37 $47.66 $63.95 53
Asset-Based
NCAV (Graham) $11.17 $14.97 $22.34 54
Growth DCF
Growth DCF $61.84 $89.08 $129.29 78
Rev-Margin DCF $39.62 $59.33 $80.81 73
Economic Profit
Residual Income $43.98 $54.75 $243.92 64
ROIC Compounder $65.79 $81.65 $98.14 72
Growth Earnings
Growth-Adj P/E $78.55 $112.21 $145.87 67

Widest divergence: Multiples ($116.62) versus Asset-Based ($14.97). Highest evidence: FCF DCF (80).

Notify me when PG reaches fair value

Put PG on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Free, no payment details. Unsubscribe anytime in one click.

Key figures & financial health

P/E ratio 21.4
P/S ratio 4.06 P/E × margin
EPS (TTM) $6.84 price ÷ EPS = P/E 21.4
Dividend yield 2.9% payout 61.8%
Net margin 19.0% FY2025
Return on equity 31.1% TTM
More key figures
Profitability
Return on assets (EBIT) 15.4% avg 5y
Operating margin 23.1% TTM
Growth
Revenue (TTM) $86.7B TTM
Revenue growth (YoY) +7.4% 3y avg +1.7%
EPS growth (YoY) +5.8%
Balance sheet & cash flow
Free cash flow $14.0B FY2025
Net debt $25.9B FY2025 · ≈ 1.8 yrs of FCF

Figures from reported company fundamentals · as of Aug 30, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 76/100

Of which business quality 71 · Market factors (momentum, volatility) 52

Profitability 73
Margins and returns on capital today
Quality Growth 46
Are margins and returns improving?
Cashflow 65
Earnings quality: real cash, not paper profit
Fin. Strength 70
Balance sheet, leverage, solvency risk
Investment 85
Disciplined investing over empire-building
Low Volatility 95
Calm price path (market factor)
Momentum 37
Price trend over the last 3–12 months (market factor)
52W Momentum 31
Distance to the 52-week high (market factor)
Net Issuance 91
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.

About the company

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care segments.

Full company description

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care segments. The company offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; antiperspirants, deodorants, and personal cleansing products under the Native, Old Spice, Safeguard, and Secret brands; and facial moisturizers, cleaners, and treatments under the Olay and SK-II brands. It also provides blades, razors, shave products, appliances, and other grooming products under the Braun, Gillette, and Venus brands. In addition, the company offers toothbrushes, toothpastes, and other oral care products under the Crest and Oral-B brands; and gastrointestinal, pain relief, rapid diagnostics, respiratory, vitamins/minerals/supplements, and other personal health care products under the Metamucil, Neurobion, Pepto-Bismol, and Vicks brands. Further, it provides fabric enhancers, and laundry additives and detergents under the Ariel, Downy, Gain, and Tide brands; and air and dish care, P&G professional, and surface care under the Cascade, Dawn, Fairy, Febreze, Mr. Clean, and Swiffer brands. Additionally, the company offers baby wipes, and taped diapers and pants under the Luvs and Pampers brands; adult incontinence and menstrual care products under the Always, Always Discreet, and Tampax brands; and paper towels, tissues, and toilet papers under the Bounty, Charmin, and Puffs brands. It sells its products through mass merchandisers, social and e-commerce channels, grocery and specialty beauty stores, membership club stores, drug and department stores, distributors, wholesalers, airport duty-free and high-frequency stores, pharmacies, electronics stores, and professional channels, as well as directly to consumers. The Procter & Gamble Company was founded in 1837 and is headquartered in Cincinnati, Ohio.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Procter & Gamble Company reported revenue of $84.3B in FY2025 versus $76.1B in FY2021, a compound +2.6%/yr. Reported net income was $16.0B in FY2025, compounding +2.8%/yr from FY2021.

Growth Quality 75/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Latest Revenue (FY 2025)
$84.3B
Latest YoY
+0.3%
Avg. revenue growth/yr (3Y) ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+1.7%
Avg. revenue growth/yr (5Y) ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+3.5%
Avg. revenue growth/yr (39Y) ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+4.4%
Value creation/yr (5Y) ⓘEarnings growth per share (CAGR 5 years) plus dividend yield: value created per share and year.
+8.5%
Earnings growth per share plus dividend yield: the value created per share and year.
Earnings growth per share+5.6%
Dividend yield2.9%
Trend ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.5Y 5.6% vs 10Y 5.8%, steady
Operating margin (EBIT) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.22.1% (2020) → 24.3% (2025) · rising
Worst earnings drop73% (2019) · in USD
Revenue +2.6%/yr
FY21 $76.1B
FY22 $80.2B
FY23 $82.0B
FY24 $84.0B
FY25 $84.3B
Net income +2.8%/yr
FY21 $14.3B
FY22 $14.7B
FY23 $14.7B
FY24 $14.9B
FY25 $16.0B
Character of growth · EPS growth decomposed (2014-2025) +6.9 % p.a.
Revenue per share +3.7 %

of which total revenue +1.9 % · buybacks/dilution +1.7 %

EBIT margin +2.5 %
Tax rate +0.5 %
Residual (interest, one-offs) +0.1 %

Annual growth per factor. These are factors, not summands: multiplied they give the EPS growth rate, added they do not quite. Start and end points are 3-year averages (details on hover).

PG screens 35% overvalued. Compare with L'Oréal S.A →

Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
Share or link this analysis
𝕏 Post WhatsApp LinkedIn Reddit
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Procter & Gamble Company · Fair Value
$108.16 −35%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "Procter & Gamble Company Fair Value". https://www.fairvalue-calculator.com/stock/PG

Recent news

External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.

Peer Group

Household & Personal Products · 246 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Valuation
Quality Score 76 · Top 25%
Fair Value upside −26% · Below median
Profitability
Return on equity (TTM) 31% · Top 25%
Return on assets 11% · Top 25%
Net margin (TTM) 19% · Top 25%
Operating margin (TTM) 23% · Top 25%
Growth and dividend
Revenue growth 7% · Above median
Dividend yield (TTM) 2.9% · Above median
Balance sheet
Debt / equity 0.48× · Highest 25%

Valuation Multiples vs Household & Personal Products median · lower = cheaper

P/E (TTM) 21.4× · Pricier than median
P/B 6.58× · Priciest 25%
P/S (TTM) 3.95× · Priciest 25%
P/FCF 24.4× · Priciest 25%
EV/EBITDA 14.3× · Pricier than median
PEG 4.13× · Priciest 25%

What the price implies (reverse DCF)

The inverse question: what free-cash-flow growth must Procter & Gamble Company deliver for ten years so that today's price is fair in our DCF model? Same formula, same discount rate as the fair value.

Implied FCF growth, 10 years+7.3 % per year
Achieved revenue growth, 5 years+3.5 % p.a.
Sector median revenue growth+3.1 %
FCF yield on price3.91 %
Discount rate (WACC) in the models7.6 %

The price demands an acceleration versus past growth: a high bar the company still has to clear. Ranking of the largest stocks →

Context: sector, industry, market

Strength profile in five axes (Snowflake)

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE0 · sector 27
FUTURE37 · sector 8
PAST100 · sector 27
HEALTH76 · sector 98
DIVIDEND58 · sector 56

VALUE 0: the price sits above our fair-value range.

Insider activity: 46/100

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Aug 30, 2026).

Stock Price Fair Value vs Fair Value
L'Oréal S.A LORL C$24.76 C$22.64 −9%
Unilever PLC UNA €55.92 €40.47 −28%
Colgate-Palmolive Company CL $88.77 $55.28 −38%
500696 500696 ₹2,093 ₹641.55 −69%
Hindustan Unilever Limited HINDUNILVR ₹2,015 ₹789.46 −61%
Kenvue Inc KVUE $18.95 $10.97 −42%
Kimberly-Clark Corporation KMB $104.96 $79.71 −24%
Henkel AG HEN3 €76.42 €85.95 +12%
The Estée Lauder Companies Inc ESLA €86.54 €18.84 −78%
Church & Dwight Co CHD $98.55 $65.12 −34%

Compare Procter & Gamble Company with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark

Frequently asked questions

Is Procter & Gamble Company (PG) overvalued or undervalued?
As of Aug 30, 2026, our model estimates a fair value of $108.16 versus a price of $146.44, about −26% upside (overvalued).
What is the fair value of PG?
Our model-based fair value for Procter & Gamble Company is $108.16 (as of Aug 30, 2026), built from audited fundamentals. The current price: $146.44.
What is the quality score of PG?
Procter & Gamble Company has a Quality Score of 76/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Procter & Gamble Company (PG)?
Our model-based price target is the fair value of $108.16 (as of Aug 30, 2026) from 24 valuation models. Cautious scenario $70.77, optimistic scenario $151.46. It is a calculation from audited fundamentals, not an analyst target.
What is the Procter & Gamble Company stock forecast for 2026?
Our models put fair value at $108.16, about −26% upside versus a price of $146.44 (overvalued). Cautious scenario $70.77, optimistic scenario $151.46. The calculation is refreshed regularly with new filings.
What is the revenue of Procter & Gamble Company (PG)?
Procter & Gamble Company reported trailing-twelve-month revenue of about $86.7B (latest available figure, as of Aug 30, 2026).
What is the net profit margin of PG?
The net profit margin of Procter & Gamble Company is about 19.2%, meaning it keeps roughly 19.2% of revenue as net income. Based on the latest reported figures.
Does Procter & Gamble Company pay a dividend?
Procter & Gamble Company currently shows a dividend yield of about 2.89% relative to its recent price (as of Aug 30, 2026).
What growth is priced into Procter & Gamble Company (PG)?
For today's price to be fair in a discounted-cash-flow model, Procter & Gamble Company would have to grow free cash flow by +7.3 % per year for ten years (discount rate 7.6 %, then 2 % perpetual growth). Over the last 5 years revenue grew +3.5 % per year. As of Aug 30, 2026.
What discount rate (WACC) does the fair value of PG use?
Our models discount Procter & Gamble Company at 7.6 %: a base by market capitalisation (mega), damped by beta 0.40, country premium for USA. The same rate applies in all 26 models.
Free · no account needed

Watch Procter & Gamble Company in the live analysis

One click puts Procter & Gamble Company on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.